Comments for Biotech Stocks Blog http://www.biotechstocksblog.com Thu, 11 Mar 2010 01:45:39 +0000 http://wordpress.org/?v=2.7.1 hourly 1 Comment on Thursday’s Top Biotech & Medical Stocks by Jaipcharp http://www.biotechstocksblog.com/2008/01/31/thursdays-top-biotech-medical-stocks-2/comment-page-1/#comment-16726 Jaipcharp Wed, 20 May 2009 19:30:37 +0000 http://www.biotechstocksblog.com/2008/01/31/thursdays-top-biotech-medical-stocks-2/#comment-16726 Outstanding information: hope to come back soon:) Outstanding information: hope to come back soon:)

]]> Comment on Previously… by Previously… | Biotech Stocks Blog | arcadegreats.com http://www.biotechstocksblog.com/2009/02/16/previously/comment-page-1/#comment-11732 Previously… | Biotech Stocks Blog | arcadegreats.com Tue, 17 Feb 2009 05:26:06 +0000 http://www.biotechstocksblog.com/2009/02/16/previously/#comment-11732 [...] Previously… | Biotech Stocks Blog [...] [...] Previously… | Biotech Stocks Blog [...]

]]> Comment on blog of interest by Zoondoreced http://www.biotechstocksblog.com/2008/06/03/latest-dtn-ethanol-news-2/comment-page-1/#comment-10747 Zoondoreced Fri, 19 Dec 2008 20:17:48 +0000 http://www.biotechstocksblog.com/2008/06/03/latest-dtn-ethanol-news-2/#comment-10747 Hello! simply super resource Hello! simply super resource

]]> Comment on Another diary date by ooopinionsss http://www.biotechstocksblog.com/2008/03/11/another-diary-date/comment-page-1/#comment-10125 ooopinionsss Wed, 03 Dec 2008 16:08:53 +0000 http://www.biotechstocksblog.com/2008/03/11/another-diary-date/#comment-10125 How you think when the economic crisis will end? I wish to make statistics of independent opinions! How you think when the economic crisis will end? I wish to make statistics of independent opinions!

]]> Comment on The Pharmaevolution by Mark http://www.biotechstocksblog.com/2008/10/15/the-pharmaevolution/comment-page-1/#comment-8958 Mark Sun, 02 Nov 2008 08:11:40 +0000 http://www.biotechstocksblog.com/2008/10/15/the-pharmaevolution/#comment-8958 great info keep up the good work great info keep up the good work

]]> Comment on NICE seeks international policy consulting partners by Leoma http://www.biotechstocksblog.com/2008/09/24/nice-seeks-international-policy-consulting-partners/comment-page-1/#comment-8915 Leoma Mon, 27 Oct 2008 15:43:25 +0000 http://www.biotechstocksblog.com/2008/09/24/nice-seeks-international-policy-consulting-partners/#comment-8915 Thanks for writing this. Thanks for writing this.

]]> Comment on NICE restricts rheumatoid arthritis treatment options by Baron http://www.biotechstocksblog.com/2008/07/24/nice-restricts-rheumatoid-arthritis-treatment-options/comment-page-1/#comment-5503 Baron Sun, 27 Jul 2008 13:58:27 +0000 http://www.biotechstocksblog.com/2008/07/24/nice-restricts-rheumatoid-arthritis-treatment-options/#comment-5503 No doubt about it, many of the decisions made by NICE are controversial to say the least. The title is National Institute for Clinical Excellence, but as far as I can see one its main functions is to limit government expenditure on expensive drugs. This is done on the grounds that they are considered (by NICE)to be ineffective in some way, or not effective enough from the cost point of view. Couple this to the fact that there is a post code lottery for drugs like anti tnf inhibitors, even when NICE has approved them, and you get a picture of inconsistency in the supply and allocation of these drugs in the UK. Socialised medicine (the NHS) certainly does not mean universally excellent free medicine and it looks as though NICE is steadily eroding many patient's access to effective treatment through limiting their clinician's choice of available drugs. NICE is wrong and inhuman to prevent those with severe Rheumatoid Arthritis from having a try at a second anti tnf inhibitor, just because they failed the first. If these people qualified for the drug in the first place (after trying all the other dmards) the expense has already been approved in principle, so it costs no more if they are put on another anti tnf. Nobody can predict in advance how a particular patient will react to a drug and it flies in the face of clinical experience to deny the opportunity of a second try. No doubt about it, many of the decisions made by NICE are
controversial to say the least. The title is National Institute for
Clinical Excellence, but as far as I can see one its main functions is
to limit government expenditure on expensive drugs. This is done on
the grounds that they are considered (by NICE)to be ineffective in some way, or
not effective enough from the cost point of view. Couple this to the fact that there is a post
code lottery for drugs like anti tnf inhibitors, even when NICE has
approved them, and you get a picture of inconsistency in the supply and
allocation of these drugs in the UK.

Socialised medicine (the NHS) certainly does not mean universally excellent free
medicine and it looks as though NICE is steadily eroding many patient’s access to effective treatment through limiting their clinician’s choice of available drugs.

NICE is wrong and inhuman to prevent those with severe Rheumatoid Arthritis from
having a try at a second anti tnf inhibitor, just because they failed
the first. If these people qualified for the drug in the first place
(after trying all the other dmards) the expense has already been
approved in principle, so it costs no more if they are put on another anti tnf. Nobody can predict in advance how a particular patient will react to a drug and it flies in the face of clinical experience to deny the opportunity of a second try.

]]> Comment on Friday’s Top Medical & Biotech Stocks by Quick Medical - Medical & Hospital Supplies http://www.biotechstocksblog.com/2008/03/16/fridays-top-medical-biotech-stocks-3/comment-page-1/#comment-422 Quick Medical - Medical & Hospital Supplies Fri, 28 Mar 2008 00:36:40 +0000 http://www.biotechstocksblog.com/2008/03/16/fridays-top-medical-biotech-stocks-3/#comment-422 I hope that as these medical supply companies increase in value, their profits will trickle down to those of us selling their products in terms of higher margins and lower costs. That would be nice :) I hope that as these medical supply companies increase in value, their profits will trickle down to those of us selling their products in terms of higher margins and lower costs. That would be nice :)

]]>